Crispr Therapeutics AG (CRSP) Shareholding Patterns
$54.56
As on 25-Sep-2026 13:34EDT
Market cap
$5,469 Mln
Revenue (TTM)
$13 Mln
P/E Ratio
--
P/B Ratio
3.2
Div. Yield
0 %
$54.56
As on 25-Sep-2026 13:34EDT
Market cap
$5,469 Mln
Revenue (TTM)
$13 Mln
P/E Ratio
--
P/B Ratio
3.2
Div. Yield
0 %